Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 4.600
-0.200 (-4.17%)
Apr 30, 2026, 6:08 PM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 891.71 million as of May 7, 2026. Its market cap has decreased by -22.03% in one year.
Market Cap
891.71M
Enterprise Value
922.52M
Revenue
74.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.60
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 891.71M, a decrease of -71.12%. That is a compound annual growth rate of -37.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 891.71M | -42.64% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.44B |
| CANbridge Pharmaceuticals | 1.21B |
| Shanghai Bio-heart Biological Technology | 1.09B |
| Transcenta Holding | 971.77M |
| Sunho Biologics | 970.43M |
| Brii Biosciences | 959.94M |
| JW (Cayman) Therapeutics Co. | 932.97M |
| 3D Medicines | 932.46M |